De-escalation of elective nodal irradiation (ENI) during definitive concurrent chemoradiotherapy (CCRT) is being actively investigated in human papillomavirus (HPV)–associated oropharyngeal carcinoma (OPC).1-6 We previously reported our experience wherein patients received 30-Gy ENI rather than traditional doses of 50 to 60 Gy, as well as omission of low-risk nodal basins.1 Two-year locoregional control (LRC) and survival were maintained and excellent quality-of-life outcomes were obtained by...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile